Homocysteine, vitamin B12 and folic acid levels in psoriasis patients

被引:40
作者
Cakmak, S. K. [1 ]
Guel, U. [1 ]
Kilic, C. [2 ]
Gonul, M. [1 ]
Soylu, S. [1 ]
Kilic, A. [1 ]
机构
[1] Ankara Numune Training & Res Hosp, Minist Hlth, Dermatol Clin 2, Ankara, Turkey
[2] Mem Hosp, Dept Biochem, Istanbul, Turkey
关键词
folic acid; homocysteine; psoriasis; vitamin B-12; PLASMA HOMOCYSTEINE;
D O I
10.1111/j.1468-3083.2008.03024.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100227 [皮肤病学];
摘要
Hyperhomocysteinaemia is a risk factor for atherosclerotic cardiovascular disease, stroke, peripheral arterial occlusive disease and venous thrombosis. An association between psoriasis and cardiovascular diseases has been reported. The aim of our study was to examine serum homocysteine, folic acid and vitamin B-12 levels in psoriasis patients. We performed a cross-sectional study in 70 consecutive outpatients with chronic plaque psoriasis and 70 age- and gender-matched controls. Serum levels of homocysteine, vitamin B-12 and folic acid levels were measured in both groups. Serum homocysteine, folic acid and vitamin B-12 levels did not differ between patient and control groups. In psoriasis patients, homocysteine levels correlated directly with psoriasis severity as measured by psoriasis area and severity index. Serum homocysteine level inversely correlated with serum folic acid levels in the patient group. Homocysteine levels correlated with psoriasis area and severity index in the patient group, which shows the disease severity. The increase in cardiovascular mortality with the severity of psoriasis might be also due to the effects of homocysteine. None declared.
引用
收藏
页码:300 / 303
页数:4
相关论文
共 12 条
[1]
Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patients [J].
Bunout, D ;
Garrido, A ;
Suazo, M ;
Kauffman, R ;
Venegas, P ;
de la Maza, P ;
Petermann, M ;
Hirsch, S .
NUTRITION, 2000, 16 (02) :107-110
[2]
DISEASE CONCOMITANCE IN PSORIASIS [J].
HENSELER, T ;
CHRISTOPHERS, E .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (06) :982-986
[3]
The importance of hyperhomocysteinemia as a risk factor for diseases: An overview [J].
Herrmann, W .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (08) :666-674
[4]
Hyperhomocysteinemia in high-aged subjects: relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation [J].
Herrmann, W ;
Quast, S ;
Ullrich, M ;
Schultze, H ;
Bodis, M ;
Geisel, J .
ATHEROSCLEROSIS, 1999, 144 (01) :91-101
[5]
Homocysteine level and coronary artery disease [J].
Kazemi, MBS ;
Eshraghian, K ;
Omrani, GR ;
Lankarani, KB ;
Hosseini, E .
ANGIOLOGY, 2006, 57 (01) :9-14
[6]
Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients [J].
Kural, BV ;
Örem, A ;
Çimsit, G ;
Uydu, HA ;
Yandi, YE ;
Alver, A .
CLINICA CHIMICA ACTA, 2003, 332 (1-2) :23-30
[7]
Ptasma homocysteine and folate levels in patients with chronic plaque psoriasis [J].
Malerba, M. ;
Gisondi, P. ;
Radaeli, A. ;
Sala, R. ;
Pinton, P. G. Calzavara ;
Girolomoni, G. .
BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (06) :1165-1169
[8]
Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients [J].
Mallbris L. ;
Akre O. ;
Granath F. ;
Yin L. ;
Lindelöf B. ;
Ekbom A. ;
Ståhle-Bäckdahl M. .
European Journal of Epidemiology, 2004, 19 (3) :225-230
[9]
Homocysteine, vitamins, and vascular disease prevention [J].
McCully, Kilmer S. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 86 (05) :1563S-1568S
[10]
FASTING PLASMA HOMOCYSTEINE AS A SENSITIVE PARAMETER OF ANTIFOLATE EFFECT - A STUDY OF PSORIASIS PATIENTS RECEIVING LOW-DOSE METHOTREXATE TREATMENT [J].
REFSUM, H ;
HELLAND, S ;
UELAND, PM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (05) :510-520